Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer
Abstract Background Uterus corpus endometrial cancer (UCEC) is the main malignant tumor in gynecology, with a high degree of heterogeneity, especially in terms of prognosis and immunotherapy efficacy. DNA methylation is one of the most important epigenetic modifications. Studying DNA methylation can...
Main Authors: | JinHui Liu, ChengJian Ji, Yichun Wang, Cheng Zhang, HongJun Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-021-02038-z |
Similar Items
-
MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer
by: Nan Lu, et al.
Published: (2021-01-01) -
Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
by: Li D, et al.
Published: (2021-09-01) -
Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer
by: Mingjun Zheng, et al.
Published: (2021-07-01) -
Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis
by: Qian Chen, et al.
Published: (2021-03-01) -
The role of CCR2 in prognosis of patients with endometrial cancer and tumor microenvironment remodeling
by: Lin Xu, et al.
Published: (2021-01-01)